[F-18 fluorodeoxyglucose positron emission tomography in neurology].
Positron emission tomography using F-18-fluorodeoxyglucose (F-18-FDG-PET) is an ideal tool for imaging regional cerebral metabolism as glucose is the most important source of energy for neurons. Under physiologic conditions the pattern of metabolism reflects the state of cerebral activation which can be modulated by various stimuli to investigate cerebral organization. Pathologic conditions usually cause a drop in metabolism because of neuronal inactivity or loss. They can, however, also be associated with an increased rate of glucose metabolism such as in case of active epileptic foci or malignant tumors. As a consequence F-18-FDG-PET has become a valuable functional imaging modality especially for the diagnostic clarification of non-contributory or negative morphologic imaging results. Dementia, pre-surgical evaluation of epilepsy and neurooncology are currently frequent indications for referral to F-18-FDG-PET in neurology.
Fazekas
F
F
Universitätsklinik für Neurologie, Karl-Franzens-Universität, Auenbruggerplatz 22, A-8036 Graz. franz.fazekas@kfunigraz.ac.at
Payer
F
F
D001921:Brain / Q000000981:diagnostic imaging / Q000503:physiopathology; D001927:Brain Diseases / Q000000981:diagnostic imaging* / Q000503:physiopathology; D001932:Brain Neoplasms / Q000000981:diagnostic imaging / Q000503:physiopathology; D003937:Diagnosis, Differential; D004734:Energy Metabolism / Q000502:physiology; D004827:Epilepsy / Q000000981:diagnostic imaging / Q000503:physiopathology; D019788:Fluorodeoxyglucose F18; D006801:Humans; D012680:Sensitivity and Specificity; D014055:Tomography, Emission-Computed
D019788:Fluorodeoxyglucose F18